CIK 0001681087
- Non-accelerated filer
- Smaller reporting company
Tectonic Therapeutic, Inc.
Sign in to watch- Ticker
- TECX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- NY
- Entity type
- Operating
- EIN
- 810710585
- Phone
- +1 339-666-3320
- Business address
- 490 ARSENAL WAY, SUITE 200, WATERTOWN, MA
- Former names
- AvroBio, Inc., AVROBIO, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $13,920
- in 2 filings, $14K under 10b5-1 plans
Net −$13,920. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-30 | McNamara Peter Chief Scientific Officer | Sale 10b5-1 | −536 | $23.04 | $12K | 54,305 |
| 2026-09-25 | McNamara Peter Chief Scientific Officer | Shares withheld for taxes 10b5-1 | −444 | $23.67 | $11K | 54,841 |
| 2026-09-03 | McNamara Peter Chief Scientific Officer | Grant or award · Employee Stock Option (Right to Buy) | +21,000 | 21,000 | ||
| 2026-08-25 | McNamara Peter Chief Scientific Officer | Exercise or conversion 10b5-1 | +43 | $14.71 | $633 | 55,328 |
| 2026-08-25 | McNamara Peter Chief Scientific Officer | Sale 10b5-1 | −43 | $36.52 | $2K | 55,285 |
| 2026-08-25 | McNamara Peter Chief Scientific Officer | Exercise or conversion · Employee Stock Option (Right to Buy) 10b5-1 | −43 | 7,787 | ||
| 2026-08-12 | McNamara Peter Chief Scientific Officer | Exercise or conversion 10b5-1 | +43 | $14.71 | $633 | 55,328 |
| 2026-08-12 | McNamara Peter Chief Scientific Officer | Sale 10b5-1 | −43 | $35.00 | $2K | 55,285 |
| 2026-08-12 | McNamara Peter Chief Scientific Officer | Exercise or conversion · Employee Stock Option (Right to Buy) 10b5-1 | −43 | 7,830 | ||
| 2026-06-30 | McNamara Peter Chief Scientific Officer | Exercise or conversion 10b5-1 | +172 | $14.71 | $3K | 55,457 |
| 2026-06-30 | McNamara Peter Chief Scientific Officer | Sale 10b5-1 | −172 | $35.00 | $6K | 55,285 |
| 2026-06-30 | McNamara Peter Chief Scientific Officer | Exercise or conversion · Employee Stock Option (Right to Buy) 10b5-1 | −172 | 7,873 | ||
| 2026-03-06 | McNamara Peter Chief Scientific Officer | Exercise or conversion 10b5-1 | +2,500 | $2.38 | $6K | 61,332 |
| 2026-03-06 | McNamara Peter Chief Scientific Officer | Exercise or conversion 10b5-1 | +215 | $14.71 | $3K | 61,547 |
| 2026-03-06 | McNamara Peter Chief Scientific Officer | Sale 10b5-1 | −6,047 | $30.00 | $181K | 55,500 |
| 2026-03-06 | McNamara Peter Chief Scientific Officer | Sale 10b5-1 | −215 | $35.00 | $8K | 55,285 |
| 2026-03-06 | McNamara Peter Chief Scientific Officer | Exercise or conversion · Employee Stock Option (Right to Buy) 10b5-1 | −2,500 | 31,959 | ||
| 2026-03-06 | McNamara Peter Chief Scientific Officer | Exercise or conversion · Employee Stock Option (Right to Buy) 10b5-1 | −215 | 8,045 | ||
| 2026-03-04 | McNamara Peter Chief Scientific Officer | Grant or award 10b5-1 | +23,000 | 60,482 | ||
| 2026-03-04 | McNamara Peter Chief Scientific Officer | Sale 10b5-1 | −1,650 | $25.00 | $41K | 58,832 |
Page 1 of 2 · 36 trades